Asia-Pacific Intravenous (IV) Equipment Market Outlook, 2028

In Asia Pacific the demand for intravenous (IV) equipment is patient safety. Healthcare professionals place a high priority on patient security and attempt to reduce the danger of infections, medication errors, and other issues related to intravenous therapy. In accordance with patient safety, the use of proficient intravenous equipment assures proper doses, lowers the danger of needlestick injuries, and improves infection control. Innovative needleless connectors, secure devices, and catheter technologies improve patient safety and increase intravenous equipment demand. The Asia-Pacific region has a rapidly aging population, with the number of people aged 65 and over expected to reach 1.3 billion by 2030. This aging population is more likely to require IV therapy due to a higher prevalence of chronic diseases such as diabetes, heart disease, and cancer.

According to the World Health Organization (WHO), there were an estimated 9.5 million new cancer cases in the Asia-Pacific region in 2020. This accounts for nearly half (49.3%) of all new cancer cases worldwide. The most common cancers in the region are lung cancer (13.8%), breast cancer (10.8%), and colorectal cancer (10.6%). The incidence of cancer in the Asia-Pacific region is expected to continue to rise in the coming years due to a number of factors, including population growth, aging, and lifestyle changes. The increasing prevalence of gastrointestinal cancer, including esophageal, gastric, liver, colon, and pancreatic cancers, is further anticipated to drive the parenteral nutrition market over the coming years.

In Asia pacific people are affected by gastrointestinal disorders, boosting the need for parenteral nutritional products that contain glutamine, phospholipids, glucose, and amino acids. Furthermore, a common symptom associated with cancer is anorexia or unintentional weight loss, creating the need for parenteral nutrition due to its effectiveness, boosting market growth.

According to the research report,"Asia-Pacific Intravenous (IV) Equipments Market Outlook, 2028,", the Intravenous (IV) Equipments market is anticipated to grow at a 7% CAGR by 2023-28. There is a growing trend towards urbanization in the Asia-Pacific region, which is leading to an increase in the number of advanced healthcare facilities. These facilities are more likely to have the latest IV equipment and technologies. Smart IV pumps are becoming increasingly popular in the Asia-Pacific region due to their ability to improve patient safety and reduce the risk of medication errors. Smart IV pumps can automatically calculate and deliver medication dosages; there is a growing trend towards the development of disposable IV equipment in the Asia-Pacific region. Disposable IV equipment is more convenient to use and can help to reduce the risk of infection. It is also more environmentally friendly than reusable IV equipment.

Home infusion therapy is becoming increasingly popular in the Asia-Pacific region as an alternative to hospital-based care. Home infusion therapy is more convenient and comfortable for patients, and it can also be more cost-effective. There is a growing demand for IV equipment that is specifically designed for certain patient populations, such as children, the elderly and obese patients. This specialized equipment can help to improve patient safety and comfort. Telemedicine is becoming more widely used in the Asia-Pacific region to manage IV therapy patients. Telemedicine can help to reduce the need for patients to travel to the hospital or clinic for IV therapy, and it can also improve patient outcomes.

There is a growing demand for IV equipment that is specifically designed for ambulatory care settings, such as surgery centers and outpatient clinics. This equipment is more portable and easier to use than traditional IV equipment, and it can help to improve patient flow and efficiency in ambulatory care settings.

China, Japan, India, Australia, and South Korea make up the various country segments of the market. Among them China is the largest market for IV equipment in the Asia Pacific region. The Chinese government is committed to improving healthcare access and quality, which is expected to drive demand for IV equipment in the coming years. China is expected to account for the largest share of the Asia Pacific IV equipment market in 2023, and this share is expected to increase in the coming years. The prevalence of chronic diseases, such as diabetes, heart disease, and cancer, is increasing in China. These diseases often require IV therapy for treatment. Lung cancer is the most common cancer in the region, both in men and women. Lung cancer incidence rates are highest in East Asia, particularly in China, Japan, and Korea. Furthermore, India is a major hub for the manufacturing of IV equipment.

The country is home to a number of leading IV equipment manufacturers, including Becton Dickinson India Private Limited, Medtronic India Private Limited, and Terumo India Private Limited. These companies are investing in research and development of new IV equipment technologies, and they are also expanding their distribution networks in India. This is an alternative to hospital-based care that is becoming increasingly popular in India. Home infusion therapy is more convenient and comfortable for patients, and it can also be more cost-effective. The Indian government is providing subsidies to healthcare providers who offer home infusion therapy, and it is also making it easier for patients to access this type of care.

There are two main subsidies that the Indian government provides to healthcare providers who offer home infusion therapy inculde The National Health Mission (NHM) Scheme and The Pradhan Mantri Jan Arogya Yojana (PMJAY) Scheme. The subsidies and other programs that the government has implemented are helping to make home infusion therapy a viable alternative to hospital-based care.

The market is segmented into various product categories, such as IV catheters, infusion pumps, administration sets, securement devices, needless connectors, stopcocks and check valves, drip chambers and others. Infusion pump technology has advanced significantly, offering features such as programmable dosing, smart infusion systems, and integration with electronic health records. These technological advancements enhance the accuracy and safety of medication delivery, making infusion pumps increasingly attractive to healthcare providers in the Asia Pacific. Infusion pumps are widely used in oncology for the administration of chemotherapy drugs.

As cancer rates increase in the Asia Pacific, particularly with a higher incidence of certain types of cancer, the demand for infusion pumps in cancer treatment regimens is on the rise. Infusion pumps are essential in pediatric and neonatal care, where precise dosing and controlled delivery of medications are critical.

The demand for infusion pumps in neonatal intensive care units (NICUs) and pediatric wards contributes to the overall growth of the Infusion Pumps segment. The expansion of telehealth services, especially accelerated by global events like the COVID-19 pandemic, has increased the demand for remote healthcare solutions. Infusion pumps play a crucial role in facilitating at-home intravenous therapies, supporting the broader adoption of telehealth in the Asia Pacific region. Government initiatives and investments in healthcare infrastructure across various Asia Pacific countries have a direct impact on the adoption of advanced medical devices, including infusion pumps. Funding and support from governments contribute to the expansion of healthcare facilities equipped with modern IV equipment.

The Asia Pacific region is experiencing demographic shifts with an increasing aging population. Elderly individuals often have chronic conditions that require on-going medical treatments, and home care settings offer a comfortable and convenient environment for administering intravenous therapies. Technological advancements have led to the development of portable and user-friendly IV equipment suitable for home care settings. Compact infusion pumps and other devices enable patients to receive intravenous therapies in the comfort of their homes, fostering the growth of the Home Care Settings segment.

Patients often prefer receiving medical care at home due to the comfort, familiarity, and reduced risk of hospital-acquired infections. The preference for home-based care drives the demand for IV equipment in home care settings, allowing patients to undergo intravenous therapies without frequent hospital visits.

Home care settings offer cost-effective solutions for both patients and healthcare systems. Avoiding hospital stays and reducing the strain on healthcare facilities contribute to the efficiency of home-based care. IV equipment designed for home use facilitates cost-effective and efficient healthcare delivery.

Companies Covered in this report:

Becton, Dickinson and Company, B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Inc., Medtronic PLC, Moog Inc., Terumo Corporation, Teleflex Incorporated, Cardinal Health, Inc., Hindustan Syringes & Medical Devices Ltd., Harsoria Healthcare Pvt Ltd, Nipro Corporation.

Considered in this report

• Geography: Asia Pacific
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• Asia Pacific IV Equipments market Outlook with its value and forecast along with its segments
• Country-wise IV Equipments market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• China
• Japan
• India
• Australia
• South Korea

By Product:

• IV Catheters
• Infusion Pumps
• Administration Sets
• Securement Devices
• Needless Connectors
• Stopcocks and Check Valves
• Drip Chambers
• Others

By End User:

• Hospital
• Clinics
• Home Care Settings
• Others

By Indication:

• Cardiovascular Disorders & Hypertension
• Pregnancy
• Diabetes
• Respiratory Diseases
• Cancer
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the IV Equipments industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.


This product will be delivered within 2 business days.